Inhaled corticosteroids use in patients with bronchiectasis: Data from the EMBARC registry
E. Polverino (Barcelona, Spain), J. Chalmers (Dundee, United Kingdom), S. Aliberti (Milan, Italy), C. Haworth (Cambridge, United Kingdom), F. Blasi (Milan, Italy), W. Boersma (Alkmaar, Netherlands), A. De Soyza (Newcastle, United Kingdom), K. Dimakou (Athens, Greece), S. Elborn (Belfast, United Kingdom), M. Loebinger (London, United Kingdom), A. Torres (Barcelona, Spain), M. Shteinberg (Haifa, Israel), T. Welte (Hannover, Germany), M. Vendrell (Girona, Spain), F. Ringshausen (Hannover, Germany), R. Menendez (Valencia, Spain), A. Shoemark (Dundee, United Kingdom), P. Burgel (Paris, France), P. Goeminne (Nikolaas, Belgium)
Source: Virtual Congress 2021 – Bronchiectasis heterogeneity: assessing the endotypes
Session: Bronchiectasis heterogeneity: assessing the endotypes
Session type: Oral Presentation
Number: 1312
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Polverino (Barcelona, Spain), J. Chalmers (Dundee, United Kingdom), S. Aliberti (Milan, Italy), C. Haworth (Cambridge, United Kingdom), F. Blasi (Milan, Italy), W. Boersma (Alkmaar, Netherlands), A. De Soyza (Newcastle, United Kingdom), K. Dimakou (Athens, Greece), S. Elborn (Belfast, United Kingdom), M. Loebinger (London, United Kingdom), A. Torres (Barcelona, Spain), M. Shteinberg (Haifa, Israel), T. Welte (Hannover, Germany), M. Vendrell (Girona, Spain), F. Ringshausen (Hannover, Germany), R. Menendez (Valencia, Spain), A. Shoemark (Dundee, United Kingdom), P. Burgel (Paris, France), P. Goeminne (Nikolaas, Belgium). Inhaled corticosteroids use in patients with bronchiectasis: Data from the EMBARC registry. 1312
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Inhaled corticosteroids in COPD: the case against Source: Eur Respir J 2009; 34: 13-16 Year: 2009
Inhaled corticosteroids in COPD: the clinical evidence Source: Eur Respir J 2015; 45: 525-537 Year: 2015
Inhaled corticosteroids in COPD: a case in favour Source: Eur Respir J 2009; 34: 10-12 Year: 2009
Inhaled steroids prescribing in patients with COPD in the community Source: Eur Respir J 2001; 18: Suppl. 33, 59s Year: 2001
Inhaled corticosteroids and COVID-19 outcomes in asthma: the Israeli experience Source: ERJ Open Res, 8 (1) 00014-2022; 10.1183/23120541.00014-2022 Year: 2022
Inhaled corticosteroid withdrawal may improve outcomes in elderly patients with COPD exacerbation: a nationwide database study Source: ERJ Open Res, 6 (1) 00246-2019; 10.1183/23120541.00246-2019 Year: 2020
Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD Source: Annual Congress 2012 - COPD: risk factors, biomarkers and diagnosis Year: 2012
Exacerbations and inhaled corticosteroids in bronchiectasis patients Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019
Tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: Lung function and safety Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD Year: 2013
What to use INSTEAD of inhaled corticosteroids in COPD? Source: Eur Respir J 2014; 44: 1391-1393 Year: 2014
Inhaled medication use in asthma and COPD Roma/Gypsies patients Source: Eur Respir J 2005; 26: Suppl. 49, 610s Year: 2005
Inhaled corticosteroids are over prescribed in patients with COPD, attending hospital Source: Eur Respir J 2006; 28: Suppl. 50, 429s Year: 2006
Rationale for use of inhaled steroids in children with bronchiectasis Source: International Congress 2019 – Insights into paediatric bronchology Year: 2019
Inhaled corticosteroids: a controversial add-on treatment in COPD Source: Eur Respir J 2010; 36: 973-974 Year: 2010
The effect of adding inhaled corticosteroids to long-acting bronchodilators for COPD: A real practice analysis in Italy Source: International Congress 2014 – Prevalence of COPD and mortality from COPD Year: 2014
Inhaled corticosteroids and the risk of a first exacerbation in COPD patients Source: Eur Respir J 2004; 23: 692-697 Year: 2004
Eligibility of patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015
Inhaled corticosteroids and pneumonia mortality in COPD patients Source: Eur Respir J, 54 (3) 1901276; 10.1183/13993003.01276-2019 Year: 2019
Inhaled corticosteroids and pneumonia mortality in COPD patients Source: Eur Respir J, 54 (3) 1901035; 10.1183/13993003.01035-2019 Year: 2019
Treatment with inhaled corticosteroids (ICS) in patients with COPD: possible way of optimisation Source: Annual Congress 2009 - Drug effects in COPD Year: 2009